Merit Medical Systems (MMSI) Stock Forecast & Price Target

Compare

345 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MMSI Analyst Ratings

Strong Buy

10 Buy

1 Hold

0 Sell

Based on 11 analysts giving stock ratings to

Merit

Medical Systems

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MMSI Stock 12 Month Forecast

Average Price Target

$103.27

▲(19.87% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for Merit Medical Systems in the last 3 months. The average price target is $103.27 with a high forecast of $122.00 and a low forecast of $95.00. The average price target represents a 19.87% change from the last price of $86.15.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"83":"$83","93":"$93","103":"$103","113":"$113","123":"$123"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":122,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$122.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":103.27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$103.27</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":95,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$95.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[83,93,103,113,123],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,84.78,87.64307692307692,90.50615384615385,93.36923076923077,96.2323076923077,99.09538461538462,101.95846153846153,104.82153846153847,107.68461538461538,110.5476923076923,113.41076923076923,116.27384615384615,119.13692307692307,{"y":122,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,84.78,86.2023076923077,87.62461538461538,89.04692307692308,90.46923076923076,91.89153846153846,93.31384615384616,94.73615384615384,96.15846153846154,97.58076923076922,99.00307692307692,100.42538461538462,101.8476923076923,{"y":103.27,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,84.78,85.56615384615385,86.35230769230769,87.13846153846154,87.92461538461538,88.71076923076923,89.49692307692308,90.28307692307692,91.06923076923077,91.85538461538462,92.64153846153846,93.42769230769231,94.21384615384615,{"y":95,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":84.12,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.68,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.61,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.8,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":104.83,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.72,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.88,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.04,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":105.45,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.2,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.64,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.98,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.78,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$122.00

Average Price Target$103.27

Lowest Price Target$95.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jack Scalprey

TR | OpenAI - 4o

$92→$95

Buy

10.27%

Upside

Upgraded

08/11/25

AI Generated ArticleAI Generated Article

John Young CFA

Canaccord Genuity

$112→$103

Buy

19.56%

Upside

Reiterated

08/05/25

Canaccord Genuity Sticks to Its Buy Rating for Merit Medical Systems (MMSI)Canaccord Genuity analyst John Young lowered the price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $103.00 (from $112.00) while maintaining a Buy rating.

Jayson Bedford

Raymond James

$108→$102

Buy

18.40%

Upside

Reiterated

07/31/25

Merit Medical Systems (MMSI) Gets a Buy from Raymond JamesRaymond James analyst Jayson Bedford lowered the price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $102.00 (from $108.00) while maintaining a Outperform rating.

Robbie Marcus

J.P. Morgan

$95

Buy

10.27%

Upside

Reiterated

07/31/25

J.P. Morgan Keeps Their Buy Rating on Merit Medical Systems (MMSI)

Larry Biegelsen

Wells Fargo

$108→$100

Buy

16.08%

Upside

Reiterated

07/31/25

Wells Fargo Remains a Buy on Merit Medical Systems (MMSI)Wells Fargo analyst Larry Biegelsen lowered the price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $100.00 (from $108.00) while maintaining a Overweight rating.

David Rescott

Robert W. Baird

$112→$103

Buy

19.56%

Upside

Reiterated

07/31/25

Merit Medical price target lowered to $103 from $112 at BairdMerit Medical price target lowered to $103 from $112 at Baird

Michael Petusky

Barrington

$103

Buy

19.56%

Upside

Reiterated

07/31/25

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (NASDAQ: MMSI), CVS Health (NYSE: CVS) and AN2 Therapeutics, Inc. (NASDAQ: ANTX)

Michael Matson

Needham

$108

Buy

25.36%

Upside

Reiterated

07/31/25

Merit Medical Systems: Strong Q2 Performance and Strategic Initiatives Justify Buy Rating

Jason Bednar

Piper Sandler

$110→$105

Buy

21.88%

Upside

Reiterated

07/31/25

Merit Medical price target lowered to $105 from $110 at Piper SandlerMerit Medical price target lowered to $105 from $110 at Piper Sandler

James Sidoti

Sidoti

$122

Buy

41.61%

Upside

Reiterated

07/08/25

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (NASDAQ: MMSI) and Soleno Therapeutics (NASDAQ: SLNO)

Craig Bijou

Bank of America Securities

$100

Hold

16.08%

Upside

Reiterated

07/07/25

Hold Rating Maintained for Merit Medical Systems Amid Leadership Change and Cautious Market Outlook

Steven Lichtman

Oppenheimer

$120→$116

Buy

34.65%

Upside

Reiterated

02/26/25

Merit Medical Systems, Inc. (MMSI) PT Lowered to $116 at OppenheimerOppenheimer analyst Steven Lichtman lowered the price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $116.00 (from $120.00) while maintaining a Outperform rating.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jack Scalprey

TR | OpenAI - 4o

$92→$95

Buy

10.27%

Upside

Upgraded

08/11/25

AI Generated ArticleAI Generated Article

John Young CFA

Canaccord Genuity

$112→$103

Buy

19.56%

Upside

Reiterated

08/05/25

Jayson Bedford

Raymond James

$108→$102

Buy

18.40%

Upside

Reiterated

07/31/25

Robbie Marcus

J.P. Morgan

$95

Buy

10.27%

Upside

Reiterated

07/31/25

J.P. Morgan Keeps Their Buy Rating on Merit Medical Systems (MMSI)

Larry Biegelsen

Wells Fargo

$108→$100

Buy

16.08%

Upside

Reiterated

07/31/25

David Rescott

Robert W. Baird

$112→$103

Buy

19.56%

Upside

Reiterated

07/31/25

Merit Medical price target lowered to $103 from $112 at BairdMerit Medical price target lowered to $103 from $112 at Baird

Michael Petusky

Barrington

$103

Buy

19.56%

Upside

Reiterated

07/31/25

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (NASDAQ: MMSI), CVS Health (NYSE: CVS) and AN2 Therapeutics, Inc. (NASDAQ: ANTX)

Michael Matson

Needham

$108

Buy

25.36%

Upside

Reiterated

07/31/25

Merit Medical Systems: Strong Q2 Performance and Strategic Initiatives Justify Buy Rating

Jason Bednar

Piper Sandler

$110→$105

Buy

21.88%

Upside

Reiterated

07/31/25

Merit Medical price target lowered to $105 from $110 at Piper SandlerMerit Medical price target lowered to $105 from $110 at Piper Sandler

James Sidoti

Sidoti

$122

Buy

41.61%

Upside

Reiterated

07/08/25

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (NASDAQ: MMSI) and Soleno Therapeutics (NASDAQ: SLNO)

Craig Bijou

Bank of America Securities

$100

Hold

16.08%

Upside

Reiterated

07/07/25

Hold Rating Maintained for Merit Medical Systems Amid Leadership Change and Cautious Market Outlook

Steven Lichtman

Oppenheimer

$120→$116

Buy

34.65%

Upside

Reiterated

02/26/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Merit Medical Systems

1 Month

xxx

Success Rate

23/32 ratings generated profit

Average Return

+4.44%

reiterated a xxx

rating 15 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 71.88% of your transactions generating a profit, with an average return of +4.44% per trade.

3 Months

xxx

Success Rate

26/32 ratings generated profit

Average Return

+10.04%

reiterated a xxx

rating 15 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 81.25% of your transactions generating a profit, with an average return of +10.04% per trade.

1 Year

Jayson BedfordRaymond James

Success Rate

21/32 ratings generated profit

Average Return

+21.63%

reiterated a buy rating 15 days ago

Copying Jayson Bedford's trades and holding each position for 1 Year would result in 65.63% of your transactions generating a profit, with an average return of +21.63% per trade.

2 Years

xxx

Success Rate

20/32 ratings generated profit

Average Return

+19.16%

reiterated a xxx

rating 15 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 62.50% of your transactions generating a profit, with an average return of +19.16% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MMSI Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MMSI has received 22 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. MMSI average Analyst price target in the past 3 months is 103.27.

Each month's total comprises the sum of three months' worth of ratings.

MMSI Financial Forecast

MMSI Earnings Forecast

Next quarter’s earnings estimate for MMSI is $0.83 with a range of $0.80 to $0.86. The previous quarter’s EPS was $1.01. MMSI beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 41.67% of the time in the same period. In the last calendar year MMSI has Outperformed its overall industry.

MMSI Sales Forecast

Next quarter’s sales forecast for MMSI is $371.91M with a range of $368.00M to $374.10M. The previous quarter’s sales results were $381.95M. MMSI beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 37.98% of the time in the same period. In the last calendar year MMSI has Outperformed its overall industry.

MMSI Stock Forecast FAQ

What is MMSI’s average 12-month price target, according to analysts?

Based on analyst ratings, Merit Medical Systems’s 12-month average price target is 103.27.

What is MMSI’s upside potential, based on the analysts’ average price target?

Merit Medical Systems has 19.87% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MMSI a Buy, Sell or Hold?

Merit Medical Systems has a consensus rating of Strong Buy which is based on 10 buy ratings, 1 hold ratings and 0 sell ratings.

What is Merit Medical Systems’s price target?

The average price target for Merit Medical Systems is 103.27. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $122.00 ,the lowest forecast is $95.00. The average price target represents 19.87% Increase from the current price of $86.15.

What do analysts say about Merit Medical Systems?

Merit Medical Systems’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of MMSI?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Merit Medical Systems (MMSI) Stock Forecast & Price Target

MMSI Analyst Ratings

MMSI Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Merit Medical Systems

MMSI Analyst Recommendation Trends

MMSI Financial Forecast

MMSI Earnings Forecast

MMSI Sales Forecast

MMSI Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts